ArticleFrontiers in aging2026
Association between frailty and incidence of AMD among middle-aged and older people: evidence from the UK Biobank.
Article in Frontiers in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To explore the association between age-related macular degeneration (AMD) and frailty and the link between frailty and neurological aging diseases in AMD patients. Methods: This study included 354,334 individuals aged ≥40 years without AMD at baseline from the UK Biobank. Frailty was assessed using the Fried phenotype. Cox proportional hazard models were used to analyze the association between frailty and AMD incidence. Logistic regression models were used to examine the link between frailty and nervous system-related diseases among AMD patients. Results: Frailty was associated with AMD incidence (hazard ratio [HR] 1.36 [95% confidence interval [95% CI] 1.29-1.44] for prefrailty; HR 2.12 [95% CI 1.86-2.42] for frailty). All five frailty components were associated with AMD: weight loss (HR 1.11 [95% CI 1.03-1.20]), exhaustion (HR 1.13 [95% CI 1.03-1.23]), low physical activity (HR 1.12 [95% CI 1.01-1.23]), low grip strength (HR 1.23 [95% CI 1.14-1.32]), and slow walking pace (HR 1.23 [95% CI 1.12-1.35]). Additionally, among AMD patients, frailty was linked to neurodegenerative diseases (odds ratio [OR] 3.09 [95% CI 1.58-6.07]), neurovascular diseases (OR 3.77 [95% CI 2.16-6.60]), and mental diseases (OR 2.09 [95% CI 1.12-3.93]). Conclusion: Frailty is a significant risk factor for AMD incidence, with all five components showing a positive association with AMD. Furthermore, frailty is linked to neural system-related diseases in AMD patients. Early detection and intervention for frailty may help prevent or delay AMD onset.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.